Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Lymphatic vessels use Reelin protein to help regulate embryonic heart growth (opens in a new tab)

medicalxpress.com · 2026-09-14

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 4 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Four of eight check out. Three claims the study doesn't address.

  • 4 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

8 claims in this story

Showing all 8 claimsChoose a verdict to focus the list.

Claim 1 of 8OverstatedThe current study says Reelin's influence extends beyond heart muscle cells and helps maintain the epicardium, a tissue essential for normal cardiac development.View evidenceHide evidence

Why this verdict

The profile supports that Reelin promotes epicardial fate in human epicardial organoids and that the broader lymphatic–epicardium network involves Wt1/Igf1 signaling. But the story’s unhedged statement that Reelin 'helps maintain the epicardium' and that this extends beyond heart muscle cells is stronger than what is directly available in the abstract-level evidence, which does not detail an in vivo Reelin-maintenance result.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

In human epicardial organoids, Reelin gain-of-function promotes epicardial fate.

“using gain-of-function approaches in human epicardial organoids, we demonstrate that Reelin promotes epicardial fate…”
Claim 2 of 8Not coveredThe article says earlier work from the Oliver laboratory showed that lymphatic vessels secrete Reelin, which promotes heart growth by promoting cardiomyocyte proliferation.View evidenceHide evidence

Why this verdict

The abstract-level profile says earlier work identified cardiac lymphatic vasculature as an unexpected regulator of embryonic heart size, and it discusses cardiomyocyte proliferation in the developmental model. However, it does not verify the specific story claim that earlier Oliver-lab work showed lymphatic vessels secrete Reelin or that Reelin promoted heart growth specifically by promoting cardiomyocyte proliferation.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
Claim 3 of 8Not coveredHearts lacking lymphatic-derived Reelin developed significant epicardial defects, lost specific fibroblast populations, and showed reduced numbers of epicardial cells expressing WT1 and IGF-1.View evidenceHide evidence

As statedsignificant

Why this verdict

The abstract-level profile supports a general loss-of-function mouse finding involving cardiac lymphatics, epicardium, Wt1, and Igf1 signaling, but it does not provide the specific details claimed here: hearts lacking lymphatic-derived Reelin, significant epicardial defects, loss of particular fibroblast populations, or reduced numbers of WT1/IGF-1-expressing epicardial cells. The magnitude term 'significant' is also not verifiable from the abstract profile.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

Single-cell transcriptomics identifies a regulatory program linking cardiac lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling…”
Claim 4 of 8Not coveredThe findings suggest lymphatics may function as organ-wide monitoring systems that help determine when growth is complete, and may inform future approaches for repairing damaged hearts and studying congenital heart defects.View evidenceHide evidence

Why this verdict

The hedged repair implication is aligned with the abstract’s suggestion that Reelin-dependent epicardial reactivation may mediate lymphatic benefits in adult cardiac repair, and the 'quality-control' idea is reflected in the profile. However, the specific broader framing as organ-wide monitoring systems determining when growth is complete, and especially the implication for congenital heart defects, is not verified in the supplied abstract-level profile.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

In human epicardial organoids, Reelin gain-of-function promotes epicardial fate.

“using gain-of-function approaches in human epicardial organoids, we demonstrate that Reelin promotes epicardial fate…”
Claim 5 of 8SupportedA Northwestern Medicine study uncovered a previously unknown signaling system that helps regulate heart growth during development.View evidenceHide evidence

As statedpreviously unknown signaling system

Why this verdict

The abstract-level profile supports a headline claim that the study uncovered a regulatory network/signaling system in which cardiac lymphatics communicate with the epicardium through Wt1 and Igf1 signaling to control late embryonic heart growth. The unhedged causal framing is supported by the reported loss-of-function mouse models, although quantitative details are not available at abstract depth.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

Single-cell transcriptomics identifies a regulatory program linking cardiac lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling…”
Claim 6 of 8SupportedThe study says lymphatic vessels do far more than transport fluid and immune cells, and that cardiac lymphatics link the epicardium and key growth genes to regulate cardiac growth.View evidenceHide evidence

Why this verdict

The paper profile supports that cardiac lymphatics have a role beyond fluid/immune-cell transport in this developmental context, linking lymphatics, the epicardium, Wt1, and Igf1 signaling to regulation of embryonic cardiac growth. The causal framing is consistent with the abstract’s description of loss-of-function mouse models combined with scRNA-seq.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

Single-cell transcriptomics identifies a regulatory program linking cardiac lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling…”
Claim 7 of 8SupportedThe researchers used single-cell RNA sequencing and genetically engineered mouse models to identify a signaling pathway linking cardiac lymphatics, the epicardium, and growth genes.View evidenceHide evidence

Why this verdict

The abstract explicitly states that the authors combined single-cell RNA sequencing with loss-of-function mouse models to uncover a regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling. 'Genetically engineered mouse models' is consistent with the profile’s loss-of-function mouse models.

1

Study evidence

Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
2

Study evidence

Single-cell transcriptomics identifies a regulatory program linking cardiac lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.

“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling…”
Claim 8 of 8SupportedIn human epicardioid organoids, treating the mini-hearts with Reelin protein increased expression of multiple epicardial markers, suggesting Reelin promotes epicardial cell fate.View evidenceHide evidence

Why this verdict

The core claim is supported: the abstract reports gain-of-function experiments in human epicardial organoids demonstrating that Reelin promotes epicardial fate. The profile does not specify the exact gain-of-function method or list the markers, so details such as direct protein treatment and 'multiple epicardial markers' are not independently assessable at abstract depth, but they do not outrun the supported central finding.

1

Study evidence

In human epicardial organoids, Reelin gain-of-function promotes epicardial fate.

“using gain-of-function approaches in human epicardial organoids, we demonstrate that Reelin promotes epicardial fate…”
Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

5 things the story did carry across
  • Central paper finding: cardiac lymphatic vasculature regulates late embryonic heart size through lymphatics–epicardium cross-talk involving Wt1 and Igf1 signaling.
  • Single-cell RNA sequencing was used with mouse loss-of-function models to identify a regulatory program linking cardiac lymphatics, epicardial state, and Igf1-pathway mitogenic outputs.
  • Reelin is a lymphatics-associated signal that promotes epicardial fate in human epicardial organoids, based on gain-of-function approaches.
  • The adult cardiac repair implication is speculative in the abstract, not a demonstrated repair outcome.
  • The human work is ex vivo organoid/basic-research evidence, not a clinical study in people.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalCardiac lymphatic vasculature regulates late embryonic heart size through a lymphatics–epicardium cross talk network involving Wt1 and Igf1 signaling.in vivo mouse loss-of-function models; single-cell RNA-seq; organoid gain-of-functionExpand

In plain English

Using loss-of-function mouse genetics together with single-cell RNA sequencing, the authors report that the cardiac lymphatic vasculature signals to the epicardium and, via a network involving Wt1 and Igf1 signaling, controls the final stages of embryonic heart growth. Perturbation of this lymphatics–epicardium–Wt1–Igf1 axis alters embryonic cardiac size. Complementary gain-of-function experiments in human epicardial organoids indicate Reelin promotes epicardial fate.

Key findings

  • Loss-of-function mouse experiments combined with scRNA-seq identify a regulatory network in which cardiac lymphatics communicate with the epicardium via Wt1 and Igf1 signaling to control the final stages of embryonic heart growth; perturbing this axis alters embryonic cardiac size.
  • Reelin promotes epicardial fate in human epicardial organoids based on gain-of-function approaches, supporting a role for Reelin in epicardial activation that may mediate lymphatic benefits in cardiac repair.
“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling that controls the final stages of embryonic cardiac growth.”
What this piece can’t prove
  • Causal inference relies on loss-of-function models as stated, but the abstract does not list controls, rescue experiments, or alternative explanations.

2 further details could not be confirmed from the summary.

2in vivo animalSingle-cell transcriptomic analysis identifies a regulatory program linking lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.scRNA-seq with computational signaling/network inferenceExpand

In plain English

Single-cell RNA sequencing of embryonic cardiac cells, with computational clustering and pathway inference, identified a transcriptomic regulatory program linking lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs that is associated with control of late embryonic cardiac growth.

Key findings

  • Single-cell transcriptomics identifies a regulatory program linking cardiac lymphatic endothelial cells, epicardial state (Wt1/epicardial maturation), and Igf1-pathway mitogenic outputs during embryonic cardiac growth.
“by combining single-cell RNA sequencing with loss-of-function mouse models, we uncover a critical regulatory network linking cardiac lymphatics, the epicardium, Wt1, and Igf1 signaling…”
What this piece can’t prove
  • The unit focuses on transcriptomic inference; functional causality is referenced as addressed elsewhere (loss-of-function models) but is not detailed within this unit's scRNA-seq description.

2 further details could not be confirmed from the summary.

3ex vivo humanReelin is a lymphatics-associated signal that promotes epicardial fate; in human epicardial organoids, Reelin gain-of-function pushes epicardial identity, suggesting a mechanism for lymphatic benefits in repair via Reelin-dependent epicardial reactivation.ex vivo human organoid gain-of-functionExpand

In plain English

The paper's abstract reports that, using gain-of-function approaches in human epicardial organoids, Reelin promotes epicardial fate; the authors propose this as a mechanism by which lymphatics could benefit adult cardiac repair via Reelin-dependent epicardial reactivation.

Key findings

  • In human epicardial organoids, Reelin gain-of-function promotes epicardial fate.
“using gain-of-function approaches in human epicardial organoids, we demonstrate that Reelin promotes epicardial fate…”
What this piece can’t prove
  • Unclear which gain-of-function approach was used (overexpression versus ligand addition), which epicardial markers or assays defined fate, and whether controls and statistical analyses support the claim.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 39 candidate papers

Candidate

Transcriptome Analysis of Secondary Metabolite Biosynthesis Genes during the Development of White Clover (Trifolium repens L.)

Russian Journal of Genetics · 2026 · Crossref

Source (opens in a new tab)

And 33 more candidates considered.